News

MENOPAUSAL THERAPY IN FOCUS — The FDA will hold a panel discussion Thursday on hormone therapy for menopausal women, a pet ...
The court-appointed Consumer Privacy Ombudsman (CPO) in the 23andMe bankruptcy last month released a 200-plus-page report ...
After Foley Hoag’s prior updates regarding the chapter 11 bankruptcy cases of 23andMe Holding Co and its affiliated debtors ...
A lawsuit against 23andMe is stirring a debate about what the proper role of government is in regulating how private companies use sensitive data.
After a couple of months of non-stop litigation, counsel for the debtor at Paul, Weiss and for the acquirer—a newly formed ...
Trump relied on far-right podcasters and close Republican politicians to win his second term, but now alliances are quickly forming against him.
A federal judge in St. Louis ruled that the sale of the direct-to-consumer genetic testing company 23andMe and its assets, despite concerns from the state of California over customer privacy.
A lawsuit against genomics firm 23andMe is stirring a debate about what the proper role of government is in regulating how private companies use sensitive data. In June, 27 states filed a lawsuit ...
DNA testing company 23andMe and Canadian plaintiffs who sued over a data breach reached a deal to allow a class proof of ...
San Francisco-based 23andMe filed for Chapter 11 bankruptcy protection in the Eastern Missouri district of federal court in March after years of financial woes.
A bankruptcy judge approved the sale of genetics company 23andMe to a non-profit led by co-founder and former CEO Anne Wojcicki, according to a June 27 filing in the bankruptcy docket.
Anne Wojcicki, founder and former CEO of 23andMe, will helm the company again after her nonprofit's purchase was approved.